Caeli Vascular is developing a series of catheter based devices for minimally invasive treatment of blood clots in large veins in the human body. Technology for the devices is licensed from Washington University in St. Louis.The Caeli Vascular Hydra system improves outcomes, enhances safety margins, and reduces costs with its multimodal closed system design.